switching from dulaglutide to semaglutide Early Dose Escalation of Tirzepatide after in Type 2 Diabetes Mellitus Dosing Patterns of Dulaglutide and

Anti-inflammatory cytokine signalling investigation

Medication Dose And Risk: What Clinicians Consider Higher doses of semaglutide and other GLP 1 agents may relate to greater weight loss and a higher chance of gallbladder complications

We already have several products within our broader product range that naturally complement any weight management programme, whether or not weight loss medications are involved, and we continue to innovate in this space. The future of GLP-1 & confectionery As GLP-1 drugs continue to reshape consumer habits, the confectionery industry faces both a challenge and an opportunity

GLP-1's roles in the body include: Stimulating insulin secretion from the pancreas in a glucose-dependent manner Suppressing glucagon (which otherwise drives the liver to release stored glucose) Slowing gastric emptying, which prolongs feelings of fullness Signaling satiety centers in the brain to reduce appetite Supporting healthy blood glucose levels already in the normal range GLP-1's challenge is that it has a very short half-life in the bloodstream (typically just 2 minutes) before an enzyme called DPP-4 breaks it down